- authorisedTherapeutic exploratory (Phase II)
RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures
This study is testing a new medicine, SPN-817, for adults who have focal onset seizures. We want to see if it helps reduce seizures and if it's safe. Some people will get the new medicine, and others will get a dummy medicine to compare the effects.
Poland · Hungary · Bulgaria - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
Spain · Poland · Bulgaria